$JNJ

JOHNSON & JOHNSON

CIK:0000200406|SEC Filings
v3.26.1
Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 29, 2026
Mar. 30, 2025
Income Statement [Abstract]    
Sales to customers (Note 9) $ 24,062 $ 21,893
Sales to customers percent to sales 100.00% 100.00%
Cost of products sold $ 8,106 $ 7,357
Cost of products sold percent to sales 33.70% 33.60%
Gross profit $ 15,956 $ 14,536
Gross Profit Percent To Sales 66.30% 66.40%
Selling, marketing and administrative expenses $ 6,034 $ 5,112
Selling marketing and administrative expenses percent to sales 25.10% 23.30%
Research and development expense $ 3,527 $ 3,225
Research and development expense percent to sales 14.70% 14.70%
In-process research and development impairments $ 36 $ 0
In-process research and development percent to sales 0.10% 0.00%
Interest income $ (229) $ (332)
Interest income percent to sales (1.00%) (1.50%)
Interest expense, net of portion capitalized $ 272 $ 204
Interest expense, net of portion capitalized percent to sales 1.20% 0.90%
Other (income) expense, net $ 294 $ (7,321)
Other (income) expense, net percent to sales 1.20% (33.40%)
Restructuring (Note 12) $ 32 $ 17
Restructuring charge percent to sales 0.10% 0.10%
Earnings before provision for taxes on income $ 5,990 $ 13,631
Earnings before provision for taxes on income percent to sales 24.90% 62.30%
Provision for taxes on income (Note 5) $ 755 $ 2,632
Provision for taxes on income percent to sales 3.10% 12.10%
Net earnings from continuing operations percent of sales 21.80% 50.20%
Net earnings $ 5,235 $ 10,999
NET EARNINGS PER SHARE    
Total net earnings per share - basic (in dollars per share) $ 2.17 $ 4.57
Total net earnings per share - diluted (in dollars per share) $ 2.14 $ 4.54
Avg. shares outstanding    
Basic (shares) 2,408.7 2,407.2
Diluted (shares) 2,445.2 2,423.8